Today: 29 April 2026

EV Stocks Today: Morgan Stanley Warns of an ‘EV Winter’ as Tesla, Rivian and Lucid Slide (December 8, 2025)

EV Stocks Today: Morgan Stanley Warns of an ‘EV Winter’ as Tesla, Rivian and Lucid Slide (December 8, 2025)

Morgan Stanley’s new auto analyst warned of an “EV winter,” projecting U.S. EV sales volumes will fall about 20% in 2026. Tesla, Rivian, and Lucid shares dropped Monday after the bank downgraded their ratings, citing slower adoption and profitability concerns. Tesla traded down 3% to $442 by mid-afternoon in New York. General Motors was upgraded, with its price target raised to $90.
8 December 2025
·····
Visa Stock Forecast 2026: HSBC Upgrade, New Price Targets and Outlook as of December 8, 2025

Visa Stock Forecast 2026: HSBC Upgrade, New Price Targets and Outlook as of December 8, 2025

Visa shares traded around $329 on December 8, down 0.8% from the prior close, after HSBC upgraded the stock to “Buy” with a $389 price target. Wall Street’s 12-month targets cluster near $400. Recent 13F filings show Natixis initiated a new stake, while SVB Wealth LLC trimmed its position but remains invested. Year-to-date, Visa’s total return trails the S&P 500.
8 December 2025
··
Semiconductor Stocks Today: AI Boom Lifts Chipmakers as Memory Shortage Deepens (Dec. 8, 2025)

Semiconductor Stocks Today: AI Boom Lifts Chipmakers as Memory Shortage Deepens (Dec. 8, 2025)

The PHLX Semiconductor Index rose 0.96% to 7,364.6 on Monday, near record highs, as chip stocks outpaced the broader market. Nvidia, Broadcom, AMD, and Micron all posted gains, with Micron up over 3% after an analyst upgrade. Fresh data showed a worsening global memory chip shortage and continued supply chain pressures. Investors focused on AI demand ahead of the Federal Reserve meeting.
8 December 2025
······
Recursion Pharmaceuticals (RXRX) Stock Jumps on Positive FAP Trial Data: Latest News, AI Drug Discovery Outlook and Analyst Forecasts

Recursion Pharmaceuticals (RXRX) Stock Jumps on Positive FAP Trial Data: Latest News, AI Drug Discovery Outlook and Analyst Forecasts

Recursion Pharmaceuticals reported Phase 1b/2 trial data showing its AI-discovered drug REC-4881 reduced polyp burden by a median 43% at 13 weeks in patients with familial adenomatous polyposis. Shares rose as much as 6% pre-market before settling in the mid-$4 range. Most patients maintained or improved reductions after stopping treatment. No approved drugs currently exist for this condition.
8 December 2025
···
Banking Stocks Today, December 8, 2025: Fed Cut Bets Steady the Sector as 2026 Outlook Brightens

Banking Stocks Today, December 8, 2025: Fed Cut Bets Steady the Sector as 2026 Outlook Brightens

The KBW Bank Index rose 0.4% to 159.7 on December 8, near its 52-week high, as investors awaited a widely expected Federal Reserve rate cut this week. Large U.S. banks traded close to multi-year highs, while European and U.K. lenders held steady on dividend support. Asian bank stocks were mixed, with India’s ICICI Bank drifting lower and Fino Payments Bank falling. Global equities remained flat ahead of the Fed decision.
8 December 2025
···
CoreWeave (CRWV) Stock Falls on $2 Billion Convertible Notes – What December 8 Means for the AI Cloud High‑Flyer

CoreWeave (CRWV) Stock Falls on $2 Billion Convertible Notes – What December 8 Means for the AI Cloud High‑Flyer

CoreWeave shares fell 5–7% to the mid-$80s Monday after the company announced a $2 billion convertible senior notes offering due 2031, with an option for $300 million more. The move adds to heavy debt taken on for AI data-center expansion. Shares traded as low as $82.40, well below the June high of $187. CoreWeave recently reported Q3 revenue of $1.36 billion, up about 134% year over year.
8 December 2025
··
Nvidia (NVDA) Stock on December 8, 2025: CUDA 13.1, Synopsys Deal and SAFE CHIPS Act Steer the Next AI Chapter

Nvidia (NVDA) Stock on December 8, 2025: CUDA 13.1, Synopsys Deal and SAFE CHIPS Act Steer the Next AI Chapter

Nvidia shares traded near $183 on December 8, 2025, following a major CUDA 13.1 software release, a $2 billion Synopsys deal, and Q3 FY26 revenue of $57 billion. The company’s market cap stands around $4.4 trillion. New U.S. export controls and China bans have heightened geopolitical risks. Wall Street’s 12-month price targets average $250–$260, with most analysts rating NVDA a “Strong Buy.”
8 December 2025
····
BigBear.ai Stock (BBAI) Today: Price, Middle East Expansion, Dilution Risks and 2026 Forecast

BigBear.ai Stock (BBAI) Today: Price, Middle East Expansion, Dilution Risks and 2026 Forecast

BigBear.ai shares traded around $6.4–$6.5 on December 8, giving the company a market cap near $3 billion. The stock is up 49% year-to-date, but revenue is falling and losses continue. The company doubled its authorized share count and short interest stands near 20%. BigBear.ai opened a new office in Abu Dhabi, expanding into the Middle East.
8 December 2025
··
Plug Power Stock Today: NASA Contract, Cash Lifeline and a Divided Wall Street – What December 8, 2025 Really Changes for PLUG

Plug Power Stock Today: NASA Contract, Cash Lifeline and a Divided Wall Street – What December 8, 2025 Really Changes for PLUG

Plug Power postponed its special shareholder meeting to January 29, 2026, with a new record date of December 12. Shares traded near $2.13 midday, valuing the company at about $3 billion. The firm announced its first liquid hydrogen supply contract with NASA, worth up to $2.8 million. Short interest remains high at around 30% of the float.
8 December 2025
··
Chevron (CVX) Stock on December 8, 2025: Price, Dividend Yield, Nigeria Push and Gorgon LNG Expansion Shape 2026 Outlook

Chevron (CVX) Stock on December 8, 2025: Price, Dividend Yield, Nigeria Push and Gorgon LNG Expansion Shape 2026 Outlook

Chevron shares traded near $150 on December 8, 2025, giving the company a $302 billion market cap and a 4.56% dividend yield. The stock is down about 5–6% over the past year as oil prices slipped to $63 per barrel for Brent. Technical indicators show a “sell” rating. Chevron’s Q3 earnings reached $3.5 billion.
8 December 2025
···
SanDisk Stock (SNDK) on December 8, 2025: JPMorgan Neutral, Susquehanna to $300 as AI Flash Leader Cools After Huge Rally

SanDisk Stock (SNDK) on December 8, 2025: JPMorgan Neutral, Susquehanna to $300 as AI Flash Leader Cools After Huge Rally

JPMorgan initiated coverage of SanDisk with a Neutral rating and $235 price target, citing risks of earnings normalization as NAND pricing peaks. Susquehanna raised its target to $300 and reiterated a Positive rating. SanDisk shares traded in the mid-$220s after surging over 500% year-to-date, following its S&P 500 debut and spin-off from Western Digital.
8 December 2025
·
Ondas Holdings (ONDS) Stock on December 8, 2025: New Ukrainian Drone Deal Caps a Wild Year for This Autonomous Defense Play

Ondas Holdings (ONDS) Stock on December 8, 2025: New Ukrainian Drone Deal Caps a Wild Year for This Autonomous Defense Play

Ondas Holdings said December 8 it will invest up to $11 million in Ukraine’s Drone Fight Group, aiming to bring DFG’s combat-tested drones to U.S. and allied markets. The announcement follows a year in which Ondas’ market cap soared to $3.4 billion, with shares trading near $9.30, up over 6,500% from a year ago. Ondas plans to manufacture the drones in the U.S. and showcase them to U.S. defense and tech leaders.
8 December 2025
··
UnitedHealth Group (UNH) Stock: 2026 Comeback Hopes After a Brutal 2025 – What Investors Need to Know Today (December 8, 2025)

UnitedHealth Group (UNH) Stock: 2026 Comeback Hopes After a Brutal 2025 – What Investors Need to Know Today (December 8, 2025)

UnitedHealth Group shares traded near $325 on December 8, 2025, down about 34% year-to-date after surging medical costs, a major cyberattack, and DOJ investigations. The company raised 2025 EPS guidance to at least $14.90 GAAP and $16.25 adjusted. UNH went ex-dividend today for a $2.21 quarterly payout, yielding 2.7%. Analyst targets imply mid-teens upside from current levels.
8 December 2025
·
HanesBrands (HBI) Stock After the Gildan Takeover: What Delisting, Deal Terms and New Forecasts Mean for Investors (Dec 8, 2025)

HanesBrands (HBI) Stock After the Gildan Takeover: What Delisting, Deal Terms and New Forecasts Mean for Investors (Dec 8, 2025)

Gildan Activewear closed its acquisition of HanesBrands on December 1, 2025, ending HBI’s status as an independent stock and triggering its delisting from the NYSE. Each HanesBrands share was exchanged for 0.102 Gildan shares plus $0.80 in cash. The deal valued HanesBrands at about $4.4 billion including debt. As of December 8, the implied value per former HBI share is approximately $6.84.
8 December 2025
···

Goldman Sachs (GS) Stock Near Record Highs After Q3 2025 Earnings Beat, $2 Billion ETF Deal and Fresh $900 Price Target

Goldman Sachs shares hit record highs near $870 as of December 8, up nearly 50% in 2025 and over 300% in five years. Q3 net revenue reached $15.18 billion with EPS of $12.25. The firm agreed to acquire Innovator Capital Management for $2 billion, adding $28 billion in ETF assets. Consensus price targets remain below current levels, with most analysts rating the stock “Hold” or “Neutral.”
8 December 2025
···
Warner Bros. Discovery Stock Surges as Paramount’s $108 Billion Hostile Bid Challenges Netflix Deal

Warner Bros. Discovery Stock Surges as Paramount’s $108 Billion Hostile Bid Challenges Netflix Deal

Paramount Skydance launched a $30-per-share hostile all-cash bid for Warner Bros. Discovery on December 8, sending WBD stock up as much as 7% to near $28. The offer, valued at about $74.4 billion in equity, bypasses the board and challenges Netflix’s earlier $82.7 billion deal. Over 43 million WBD shares traded, several times normal volume. The tender offer expires in early January 2026 unless extended.
8 December 2025
··
Marvell Technology (MRVL) Stock Slides as Microsoft and Amazon Fears Collide With a Bullish AI Roadmap

Marvell Technology (MRVL) Stock Slides as Microsoft and Amazon Fears Collide With a Bullish AI Roadmap

Marvell Technology shares fell about 9% to near $90 midday Monday after reports Microsoft may shift custom AI chip work to Broadcom and a Benchmark downgrade citing possible AI design losses at AWS. The drop follows Marvell’s record AI results and a major optical networking investment. JPMorgan maintained an “Overweight” rating, dismissing concerns over Microsoft and AWS share losses.
8 December 2025
··
AppLovin (APP) Stock Surges on AI Momentum: Latest News, Analyst Targets and 2025–2030 Forecasts (December 8, 2025)

AppLovin (APP) Stock Surges on AI Momentum: Latest News, Analyst Targets and 2025–2030 Forecasts (December 8, 2025)

AppLovin shares traded near $700 on December 8, 2025, up about 1% and close to their September record high. Piper Sandler reaffirmed its Overweight rating and $800 price target after an investor meeting, citing nearly 99% revenue growth and strong margins. The stock is up 83% over the past year, with a trailing P/E near 84. L2 Asset Management reduced its APP stake by about 52% in Q2.
8 December 2025
··
1 … 1,298 1,299 1,300 1,301 1,302 … 1,882

Stock Market Today

  • Sugar Prices Rise Sharply Amid Gasoline Surge and Ethanol Demand
    April 29, 2026, 5:48 PM EDT. Sugar prices surged on Wednesday, with New York sugar hitting a three-week high and London sugar a four-week high. The rally comes as gasoline prices climbed to a 3.75-year peak, boosting ethanol prices and encouraging Brazil's sugar mills to divert cane crushing towards ethanol rather than sugar, tightening sugar supplies. Brazil's 2026/27 sugar output is forecasted to decline slightly, while ethanol production is set to increase by 7.2%, according to Conab. The USDA projects a 3% drop in Brazil's sugar output for 2026/27, reinforcing price support. Analysts, including Covrig Analytics and Czarnikow, have cut global sugar surplus estimates sharply for 2025/26 and 2026/27, signaling a reduced global sugar glut. These developments reversed recent price pressure caused by ample supplies and weak demand.

Latest article

Meta Stock Slides as $145 Billion AI Spending Plan Overshadows Blowout Earnings

Meta Stock Slides as $145 Billion AI Spending Plan Overshadows Blowout Earnings

29 April 2026
MENLO PARK, California, April 29, 2026, 14:01 PDT Meta Platforms shares fell in extended trading on Wednesday after the Facebook owner raised its 2026 capital spending forecast, a sign investors are still testing how far they will let Big Tech go in the AI buildout before demanding clearer returns. The company now expects capital expenditures of $125 billion to $145 billion, up from $115 billion to $135 billion, and its shares were down around 5% after hours. (Reuters) The move mattered more than the earnings beat. Meta is telling Wall Street that artificial intelligence will keep requiring vast sums for
Chipotle Stock Jumps After Chicken Bet Breaks Its Sales Slump

Chipotle Stock Jumps After Chicken Bet Breaks Its Sales Slump

29 April 2026
Chipotle Mexican Grill reported a 0.5% rise in first-quarter comparable sales, reversing recent declines and beating analyst expectations. Total revenue rose 7.4% to $3.09 billion, while shares jumped 7% in after-hours trading. Operating margin narrowed to 12.9% from 16.7% a year earlier. Menu items like Chicken al Pastor and Honey Chicken drove increased restaurant visits.
AI Stocks Today: Big Tech Earnings Just Put the Market’s Hottest Trade on Notice

AI Stocks Today: Big Tech Earnings Just Put the Market’s Hottest Trade on Notice

29 April 2026
Alphabet shares jumped over 3% in after-hours trading Wednesday as Google Cloud revenue surged 63% to $20 billion. Meta, Amazon, and Microsoft fell, with Meta dropping more than 6% after raising its 2026 capital spending forecast for AI infrastructure. Amazon’s AWS revenue beat estimates but shares slipped. The four companies are expected to spend over $600 billion on AI infrastructure this year.
Go toTop